Obstructive Valvular and Non-Valvular Lesions | Medibuddy
7th May 2025

Obstructive Valvular and Non-Valvular Lesions

Coarctation of the Aorta

Coarctation_Of_Aorta

Image Source: Wikimedia Commons (2016). Coarctation Of Aorta, Licensed under a creative commons licence. Available for free at: 

https://upload.wikimedia.org/wikipedia/commons/3/30/Coarctation_Of_Aorta.png?20160926151738 (Accessed 2 May 2025).

Coarctation of the aorta (CoA), or aortic coarctation, describes a vasculature abnormality with a narrowing of the descending aorta. Most often, this lesion is located distal to the left subclavian artery, i.e., the insertion site for the ductus arteriosus. A consequence of CoA is increased left ventricular pressure due to increased left ventricular outflow resistance. This syndrome is described in Table Eight.

Feature Summary
Epidemiology Mostly sporadic

Prevalence of 4 in 10,000 live births and is more common in males

Often associated with VSD and bicuspid aortic valve

Aetiology Congenital manifestation is still not fully understood. However, two theories exist.

  1. Limited antegrade blood flow during foetal development, resulting in maldevelopment of the aortic arch
  2. Ductal tissue migration into the thoracic aortic wall during development

Genetics, e.g. Turner syndrome, DiGeorge

Acquired presentation is rare but can be related to Takayasu arteritis

Classification Several strategies exist, but they are commonly based on location

  1. Juxtaductal – insertion of ductus arteriosus (most common)
  2. Other (preductal, abdominal, infrarenal) – proximal to the left subclavian artery or within the abdominal aorta (less common)
  3. Tubular Hypoplasia – enlarged narrowed segment (rare)
Clinical History In mild or moderate cases, patients are often asymptomatic. In severe cases, these present in the neonate when the ductus arteriosus closes and presents with shock, hypotension and cyanosis.

Potential features within a clinical history include:

  1. Early onset hypertension or hypertension resistant to antihypertensives
  2. Lower limb claudication
Clinical Examination Reduced palpable pulses in the lower limbs

Difference in the upper and lower limb blood pressure

Ejection systolic murmur – heard loudest in the left upper sternal border or back

Male

Investigations ECG – often normal, or may show left or right ventricular hypertrophy

CXR – features depend on the severity and age. It can be normal, have posterior rib notching (collateral vessel enlargement) or cardiomegaly (pulmonary venous congestion)

Echocardiogram – definitive and will show a discrete thoracic aortic narrowing with a pressure gradient.

Diagnostic Criteria This criterion allows for the deduction of the clinical severity of the CoA.

  1. Mild-to-Moderate
    1. Asymptomatic or hypertension
    2. Enlarged collateral vessels permit blood flow around the narrowing
  2. Severe
    1. Critical presentation within the neonate
    2. Closure of the ductus arteriosus causes cardiogenic shock
Management The main goal is a complete repair of the coarctation with no residual pressure gradient. The choice depends on the clinical presentation and severity.

Severe coarctation in the neonate requires prostaglandin E1 to maintain ductus arteriosus patency and then emergency surgical repair.

Non-critical coarctation repair is dependent on the age of the patient. If less than one year, then surgical repair is often used. If older than one year, then surgical or percutaneous repair is utilised.

If there is recurrent coarctation, then stent or balloon angioplasty is utilised.

Follow Up Patients will require indefinite follow-ups with a suitable cardiologist.

Complications include treatment resistant hypertension resulting in coronary artery disease, cerebral aneurysm, aortic dissection, aortic pseudoaneurysm or coarctation recurrence.

Prognosis is often excellent in those with isolated CoA but often will require life-long antihypertensive treatment and cardiology follow-up. In the context of other abnormalities, there is a higher risk of long-term complications.

Table 8: The above table details the main findings regarding coarctation of the aorta, sourced and adapted from Gossett, Coarctation of the Aorta: BMJ Best Practice; 2023 and Hijazi, Clinical manifestations and diagnosis of coarctation of the aorta: UpToDate; 2023.

Pulmonary Stenosis

Pulmonary_valve_stenosis.svg

Image Source: Wikimedia Commons (2016). Pulmonary Valve Stenosis, Licensed under a creative commons licence. Available for free at: 

https://upload.wikimedia.org/wikipedia/commons/thumb/7/7f/Pulmonary_valve_stenosis.svg/1232px-Pulmonary_valve_stenosis.svg.png?20070716043327 (Accessed 2 May 2025).

Pulmonary stenosis (PS) is an obstruction of blood flow from the right ventricle into the pulmonary vasculature. The obstruction results in a pressure gradient across the pulmonary valve of over 10mmHg during systole. Around 80% of cases are due to the pulmonary valve, but other variants can arise distally and proximal, and it is most commonly present in the context of other CHDs. The clinical picture is variable, ranging from asymptomatic to extreme cyanosis and even death. The main features associated with PS can be reviewed in Table Nine.

Feature Summary
Epidemiology Present in 7% of all children with CHD

Occurs in more females

Aetiology Most are congenital in nature

The key consequence of PS is increased right ventricular strain and pressure. In mild-to-moderate cases, patients are often acyanotic and without cardiac signs. However, in severe cases, right ventricular failure can result.

Classification Often this is via the location of the obstruction

  1. Valvular
  2. Supravalvular ( e.g. intracavitary or infundibular)
  3. Subvalvular
  4. Peripheral (or branch)
Clinical History Even without intervention, survival into adulthood is typical, but this can result in calcification and fibrotic changes of the pulmonary valve.

Mild-to-moderate cases are often asymptomatic. However, severe PS may report syncope on exertion, chest pain, exertional dyspnoea and fatigue.

Clinical Examination Common examination findings include:

  1. Ejection systolic murmur loudest at the left upper sternal edge
  2. Right ventricular heave (left sternal edge)
  3. Signs of right-sided heart failure, e.g. peripheral oedema, hepatomegaly, raised JVP.
  4. Cyanosis (if ADS or PFO is present)

Dysmorphic features, e.g. Noonan, Williams

Investigations ECG – normal (mild), right ventricular conduction delay and right axis deviation (moderate), right atrial enlargement and extreme right axis deviation (severe)

Chest X-ray – normal (mild or moderate), cardiomegaly/right ventricular or atrial enlargement (severe)

Echocardiogram with Doppler – visualisation of valvular pathology and systolic pressure gradient

Management Treatment of PS depends on the severity of the disease

  1. Mild PS – rarely progresses, therefore observation and monitoring
  2. Moderate PS – percutaneous balloon pulmonary valvuloplasty or surgical valvuloplasty
  3. Severe PS
  1. No cyanosis or respiratory distress
    1. Percutaneous balloon pulmonary valvuloplasty or surgical valvuloplasty
  2. Cyanosis or respiratory distress
    1. Oxygen supplementation and prostaglandin E1 to maintain ductus arteriosus patency and percutaneous balloon pulmonary valvuloplasty
    2. Surgical valvuloplasty
Follow Up Outpatient monitoring for signs of progression (mild PS), but more frequent follow-up is needed in patients who have undergone a procedure.

Potential complications include pulmonary valve insufficiency after valvuloplasty, right-sided heart failure, and risk associated with valvuloplasty procedure.

The prognosis is related to PS severity. In mild PS, even if untreated, survival is similar to that of the general population. In critical PS, if there is no intervention, then it is a terminal presentation in the neonate. In PS requiring surgical intervention, the outcome is impacted by younger age at the point of intervention, a higher initial pressure gradient and a high residual gradient.

Table 9: The above table outlines the main features relating to pulmonary stenosis, sourced and adapted from Asnes and Keesham, Pulmonary Stenosis: BMJ Best Practice 2022 and Stout, Clinical manifestations and diagnosis of pulmonic stenosis in adults: UpToDate; 2021.

Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.